Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
在 NextNav 上押注超過 200 萬美元？看看內部人士正在積極買入的這3只細價股
The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週三收盤上漲400多點。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。
NextNav
下一頁導航
- The Trade: NextNav Inc. (NASDAQ:NN) 10% owner Joseph D Samberg acquired a total of 483,000 shares an average price of $4.52. To acquire these shares, it cost around $2.18 million. The company's Director Neil S Subin also bought 150,000 shares of the company.
- What's Happening: On March 13, NextNav reported worse-than-expected fourth-quarter GAAP EPS results.
- What NextNav Does: NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation and Timing services in the absence of GPS.
- 交易：NextNav Inc.（納斯達克股票代碼：NN）10% 的所有者 Joseph D Samberg 共收購了483,000股股票 平均價格爲4.52美元。收購這些股票的成本約爲218萬美元。該公司董事尼爾·蘇賓還購買了該公司的15萬股股份。
- 發生了什麼：3月13日，NextNav公佈的第四季度GAAP每股收益業績低於預期。
- NextNav 做什麼：NextNav Inc 提供 GPS 服務。該公司的NextNav TerraPoint系統在沒有GPS的情況下通過可靠的定位、導航和計時服務來保持關鍵基礎設施的彈性。
Eyenovia
Eyenovia
- The Trade: Eyenovia, Inc. (NASDAQ:EYEN) 10% owner Stuart M. Grant acquired a total of 50,000 shares at at an average price of $1.23. To acquire these shares, it cost around $61,500.00.
- What's Happening: On March 18, Eyenovia reported worse-than-expected fourth-quarter financial results.
- What Eyenovia Does: Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology.
- 交易：Eyenovia, Inc.（納斯達克股票代碼：EYEN）10% 的所有者斯圖爾特·格蘭特 共收購了 50,000 股股票 平均價格爲1.23美元。收購這些股票的成本約爲61,500.00美元。
- 發生了什麼：3月18日，Eyenovia公佈的第四季度財務業績低於預期。
- Eyenovia做什麼：Eyenovia Inc是一家臨床階段的眼科公司，基於其專有陣列打印（MAP）平台技術開發一系列療法。
Ovid Therapeutics
Ovid 療法
- The Trade: Ovid Therapeutics Inc. (NASDAQ:OVID) CEO Jeremy M Levin acquired a total of 18,248 shares at an average price of $2.76. The insider spent around $50,365 to buy those shares.
- What's Happening: On March 8, Ovid Therapeutics posted upbeat quarterly sales.
- What Ovid Therapeutics Does: Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders.
- 交易：Ovid Therapeutics Inc.（納斯達克股票代碼：OVID）首席執行官傑里米·萊文 共收購了18,248股股票 平均價格爲2.76美元。知情人士花費了約50,365美元購買了這些股票。
- 發生了什麼：3月8日，Ovid Therapeutics公佈了樂觀的季度銷售額。
- Ovid Therapeutics做什麼：Ovid Therapeutics Inc是一家生物製藥公司，致力於減少癲癇發作，切實改善受罕見癲癇和癲癇發作相關神經系統疾病影響的人的生活。
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道